0 NYSE Companies - January 22, 2019Rexahn Presents Updated Preliminary Data on RX-3117 in Pancreatic Cancer at the 2019 ASCO GI SymposiumOverall Response Rate of 38% Observed in the First 24 Patients Who Had At Least One Scan on Treatment ROCKVILLE, […]Read More
0 NASDAQ Companies - January 22, 2019Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) DeficiencyLEXINGTON, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]Read More
0 NASDAQ Companies - January 22, 2019Onconova Therapeutics, Inc. to Present at the NobleCON 15th Annual Investor Conference in Fort Lauderdale, FLNEWTOWN, Pa., Jan. 22, 2019 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused […]Read More
0 NASDAQ Companies - January 22, 2019Eagle Bulk Shipping Inc. Receives Commitment for a New Credit Facility Totaling USD 208 MillionSTAMFORD, Conn., Jan. 22, 2019 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle” or the “Company”) announced today […]Read More
0 NASDAQ Companies - January 22, 2019Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature MedicinePublication Highlights Encouraging Evidence of OTL-300’s Safety and Efficacy in Transfusion-Dependent Beta-Thalassemia Patients BOSTON and LONDON, Jan. 22, 2019 (GLOBE […]Read More
0 NASDAQ Companies - January 22, 2019Union Bankshares Reports Fourth Quarter and Full Year ResultsRICHMOND, Va., Jan. 22, 2019 (GLOBE NEWSWIRE) — Union Bankshares Corporation (the “Company” or “Union”) (Nasdaq: UBSH) today reported net […]Read More
0 NASDAQ Companies - January 22, 2019Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMASix Minute Walk Test Acceptable as Primary Efficacy Endpoint for Potential Registration Program SOUTH SAN FRANCISCO, Calif., Jan. 22, 2019 […]Read More
0 NASDAQ Companies - January 22, 2019TG Therapeutics Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Umbralisib for the Treatment of Marginal Zone LymphomaBreakthrough Therapy Designation granted based on interim data from the Marginal Zone Lymphoma cohort of the UNITY-NHL trial NEW YORK, […]Read More
0 NASDAQ Companies - January 22, 2019Top Ships Inc. Announces Completion of Senior Secured Post-Delivery Financing for M/T Eco CaliforniaATHENS, Greece, Jan. 22, 2019 (GLOBE NEWSWIRE) — TOP Ships Inc. (the “Company”), an international owner and operator of modern, […]Read More
0 NASDAQ Companies - January 22, 2019IRADIMED CORPORATION to Hold 2018 Fourth Quarter Financial Results Conference Call on February 6thWINTER SPRINGS, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its […]Read More